RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Akebia Therapeutics Revenue 2024

Akebia Therapeutics Revenue

192.87 M USD

Akebia Therapeutics Dividend yield

Ticker

AKBA

ISIN

US00972D1054

WKN

A1XF0S

In 2024, Akebia Therapeutics's sales reached 192.87 M USD, a -0.9% difference from the 194.62 M USD sales recorded in the previous year.

The Akebia Therapeutics Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2029e543.8528,48
2028e453.1834,18
2027e334.2646,33
2026e242.1563,96
2025e174.9288,54
2024e192.8780,30
2023194.6279,58
2022292.592,31
2021211.751,25
2020294.655,13
201933566,42
2018207.796,97
2017181.2100,00
20161.510325,27
2015--
2014--
2013--
2012--
2011--

Akebia Therapeutics Aktienanalyse

What does Akebia Therapeutics do?

Akebia Therapeutics Inc. is a biopharmaceutical company based in Cambridge, Massachusetts, USA. The company was founded in 2007 and focuses on the development and marketing of medications for the treatment of kidney diseases and other diseases. Akebia Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Akebia Therapeutics's Sales Figures

The sales figures of Akebia Therapeutics originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Akebia Therapeutics’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Akebia Therapeutics's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Akebia Therapeutics’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Akebia Therapeutics Stock

How much revenue did Akebia Therapeutics generate this year?

Akebia Therapeutics has achieved a revenue of 192.87 M USD this year.

How much was the turnover of the company Akebia Therapeutics compared to the previous year?

The revenue of Akebia Therapeutics has increased by -0.9% decreased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Akebia Therapeutics?

The revenue of Akebia Therapeutics is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Akebia Therapeutics measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Akebia Therapeutics so important for investors?

The revenue of Akebia Therapeutics is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Akebia Therapeutics pay?

Over the past 12 months, Akebia Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Akebia Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Akebia Therapeutics?

The current dividend yield of Akebia Therapeutics is .

When does Akebia Therapeutics pay dividends?

Akebia Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Akebia Therapeutics?

Akebia Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Akebia Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Akebia Therapeutics located?

Akebia Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Akebia Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Akebia Therapeutics from 5/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/19/2024.

When did Akebia Therapeutics pay the last dividend?

The last dividend was paid out on 5/19/2024.

What was the dividend of Akebia Therapeutics in the year 2023?

In the year 2023, Akebia Therapeutics distributed 0 USD as dividends.

In which currency does Akebia Therapeutics pay out the dividend?

The dividends of Akebia Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Akebia Therapeutics stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Akebia Therapeutics

Our stock analysis for Akebia Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Akebia Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.